Skip to content
by Legal Desire
23 May 2023

Latham & Watkins Advises Ironwood Pharmaceuticals in Acquisition of VectivBio

Advising firms

Deal team

23 lawyers named
LawyerFirmSeniorityPracticeOffice
Charles Ruck Lead Latham & Watkins LLP Partner corporate Orange County
Daniel Rees Lead Latham & Watkins LLP Partner corporate Orange County
Andrew Clark Lead Latham & Watkins LLP Partner corporate Los Angeles
Ian Nussbaum Lead Latham & Watkins LLP Partner corporate New York
Brian Umanoff Latham & Watkins LLP Associate corporate Orange County
Taylor Ashton Latham & Watkins LLP Associate corporate Orange County
Mekbeb Hagos Latham & Watkins LLP Associate corporate Orange County
Stephanie Teicher Latham & Watkins LLP Partner finance New York
Sara Shahmiri Latham & Watkins LLP Associate finance New York
Jacob Sikora Latham & Watkins LLP Associate finance New York
David Raab Latham & Watkins LLP Partner tax New York
Abigail Friedman Latham & Watkins LLP Associate tax New York
Morgan Brubaker Latham & Watkins LLP Partner IP and data privacy Washington, D.C.
Clayton Northouse Latham & Watkins LLP Partner IP and data privacy Washington, D.C.
Jane Bentham Latham & Watkins LLP Associate IP and data privacy London
Ami Sodha Latham & Watkins LLP Associate IP and data privacy London
Michelle Carpenter Latham & Watkins LLP Partner benefits and compensation Los Angeles
Ben Haas Latham & Watkins LLP Partner FDA and healthcare regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner Not stated Bay Area
Eveline Van Keymeulan Latham & Watkins LLP Partner Not stated Paris
Chad Jennings Latham & Watkins LLP Counsel Not stated Washington, D.C.
Joshua Holian Latham & Watkins LLP Partner antitrust San Francisco
Patrick English Latham & Watkins LLP Counsel antitrust Washington, D.C.

Stated terms

Stated value
USD 1bn (approximately US$1 billion)
What the figure measures
Total transaction value
Client
Ironwood Pharmaceuticals, Inc.Buy-side
Counterparties
VectivBio Holding AG (Sell-side)